Afuresertib Completed Phase 2 Trials for Langerhans Cell Histiocytosis (LCH) Basic Science
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Basic Science | 2 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT01395004 | A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis |